In This Section

Program: Thursday, February 19

Wednesday, Feb. 18 Friday, Feb 20 Saturday, Feb. 21

THURSDAY, FEBRUARY 19

Thursday, February 19

Breakfast

7-8 a.m.

Keynote Session 2

8-9:20 a.m.

  • 8 a.m. | Introduction of Keynote Speaker
    Nina Bhardwaj
  • 8:05 a.m. | Rafi Ahmed, Emory University, Atlanta, Georgia
  • 8:40 a.m. | Introduction of Keynote Speaker
    Antoni Ribas
  • 8:45 a.m. | Keynote speaker to be announced

Break

9:20-9:30 a.m.

Major Symposia 1-2

9:30-11 a.m.

Major Symposium 1: Cellular Therapies for Solid Cancers

Session Chair: Christian S. Hinrichs, Rutgers Cancer Institute of New Jersey, Piscataway, New Jersey

  • 9:35 a.m. | Christian S. Hinrichs
  • 9:55 a.m. | Louai Labanieh, Icahn School of Medicine at Mount Sinai, New York, New York

Short talks selected from highly rated abstracts

Major Symposium 2: Immune Suppressive Myeloid Cells

Session Chair: Marco Colonna, Washington University School of Medicine in St. Louis, St. Louis, Missouri

  • 9:35 a.m. | Marco Colonna
  • 9:55 a.m. | Spatial and molecular control of tumor immune microenvironment
    Renato Ostuni, IRCCS Ospedale San Raffaele, Milan, Italy

Short talks selected from highly rated abstracts

Break

11-11:15 a.m.

Spotlight on Proffered Papers Session 1

11:15 a.m.-12 p.m.

Session Chair: Nina Bhardwaj, Icahn School of Medicine at Mount Sinai, New York, New York

Short talks selected from highly rated abstracts

Poster Session B / Exhibit Show / Lunch

12:15-3:15 p.m.

Major Symposia 3-4

3:15-4:45 p.m.

Major Symposium 3: Regulation of Immune Response to Cancer

Session Chair: Padmanee Sharma, The University of Texas MD Anderson Cancer Center, Houston, Texas

  • 3:20 p.m. | From the clinic to the lab: Investigating mechanisms of response and resistance to immune checkpoint therapy
    Padmanee Sharma
  • 3:40 p.m. | The T cell ‘exhaustion’ transcriptional program downstream of NFAT
    Patrick Hogan, La Jolla Institute for Immunology, La Jolla, California

Short talks selected from highly rated abstracts

Major Symposium 4: NK Cells in IO

Session Chair: Katayoun Rezvani, The University of Texas MD Anderson Cancer Center, Houston, Texas

  • 3:20 p.m. | Optimizing NK cell engineering for therapeutic efficacy
    Katayoun Rezvani
  • 3:40 p.m. | Eric Vivier, Innate Pharma, Marseille, France

Short talks selected from highly rated abstracts

Break

4:45-5 p.m.

Spotlight Sessions 1-2

5-6:20 p.m.

Spotlight Session 1: Artificial Intelligence and Design of Immune Modulators

Session Chair: David M. Reese, Amgen, Inc., Thousand Oaks, California

  • 5:05 p.m. | Molecular engineering in the era of artificial intelligence
    David M. Reese
  • 5:25 p.m. | Gevorg Grigoryan, Generate Biomedicines, Somerville, Massachusetts

Short talks selected from highly rated abstracts

Spotlight Session 2: in situ Vaccination

Session Chair: Michael J. Mitchell, University of Pennsylvania, Philadelphia, Pennsylvania

  • 5:05 p.m. | Michael J. Mitchell
  • 5:25 p.m. | Haydn T. Kissick, Emory University, Atlanta, Georgia

Short talks selected from highly rated abstracts

Evening off / Dinner on own

6:20 p.m.